Literature DB >> 25303354

How to assess intensive care randomized trials.

Anna Maria Buehler1, Alexandre Biasi Cavalcanti1, Erica Aranha Suzumura1, Mariana Teixeira Carballo1, Otávio Berwanger1.   

Abstract

Randomized controlled trials are scientific investigations considered as the gold-standard to evaluate therapeutic interventions. Randomized controlled trials may examine the safety and efficacy of new drugs and therapeutic procedures or compare the effects of two or more drugs or any other intervention. In this article, we present the essential features of these studies, as well as, factors which may bias randomized controlled trials. We also present criteria to critically appraise articles reporting randomized controlled trials, explain how to interpret the results and how to apply them to clinical practice.

Year:  2009        PMID: 25303354

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  2 in total

1.  Different research designs and their characteristics in intensive care.

Authors:  Wagner Luis Nedel; Fernando da Silveira
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

2.  Quality of clinical studies present in the package inserts of coagulation factors used in the treatment of hemophilia.

Authors:  Yasmin Gonçalves Araújo; João Pedro Vasconcelos Paolinelli; Janaina Souza Dias Pichitelli; Danyelle Romana Alves Rios; Nayara Ragi Baldoni; André Oliveira Baldoni
Journal:  Einstein (Sao Paulo)       Date:  2022-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.